Home HOME General Physiology and Biophysics 2009 General Physiology and Biophysics Vol.28, No.3, p.294–301, 2009

Journal info


Quarterly, 80 pp. per issue
Founded: 1982
ISSN  1338-4325 (online)

Published in English

Aims and Scope
Editorial Info
Abstracting and Indexing
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.


General Physiology and Biophysics Vol.28, No.3, p.294–301, 2009

Title: Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-alpha
Author: Daniela Krejčová, Jiřina Procházková, Lukáš Kubala and Jiří Pacherník

Abstract: Treatments of non-small cell lung cancer (NSCLC), the most common form of lung cancer, still remain poor. Interferon alpha (IFN-α), an important physiological immunomodulator, possesses direct cytotoxic and cytostatic effects on tumour cells, antiangiogenic effects, and activates anti-tumour immunity. Recently, the IFN-α oncologic indications have included melanoma, renal carcinoma, and different types of leukaemia. However, the application of IFN-α in therapy of lung cancer has not been validated yet. Herein the human lung carcinoma cell line A549, a model of NSCLC in vitro, was used to pursue the effect of IFN-α on A549 cell proliferation and differentiation together with the effect on protein expression and activity of three ATP-transporters mediating multi-drug resistance (MDR). IFN-α significantly inhibited the proliferation of A549 cells which was not connected with arrest in a particular cell cycle phase. Further, IFN-α-mediated differentiation of A549 was observed based on an increase in alkaline phosphatase activity. Simultaneously, IFN-α increased the expression and activity of ATP-transporters mediating MDR. Thus, the IFN-α down-regulation of NSCLC cell proliferation was accompanied by a potential of cells to exclude potential therapeutic substances such as chemotherapeutic agents. These effects could have a significant impact on considerations of IFN-α as a therapeutic agent for NSCLC.

Keywords: Non-small cell lung cancer — ABC transporter proteins — Cell cycle — Interferons
Year: 2009, Volume: 28, Issue: 3 Page From: 294, Page To: 301
doi:10.4149/gpb_2009_03_294


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.